Source: Healthcare Business Today In the fast-evolving healthcare industry, the quest for innovative therapies is often hindered by formidable obstacles, chief among them being the
Source: HealthIT Answers The landscape of drug development is fraught with escalating costs and formidable challenges. Lengthy timelines, exorbitant expenses, and regulatory hurdles often impede
Source: American Pharmaceutical Review In recent years, transformative strides in the treatment of sickle cell disease (SCD) have materialized with the FDA’s approval of groundbreaking
Source: Western Pennsylvania Healthcare News The recent Food and Drug Administration (FDA) approval of cell-based gene therapies for Sickle Cell Disease (SCD) marks a groundbreaking
Source: Rare Disease and Orphan Drug Journal Abstract One of the main challenges in rare diseases is the unavailability of reliable estimates of prevalence and
Source: PRWeb The Food and Drug Administration has approved 16 new gene therapies to date, but for most people around the world, these expensive treatments
Source: PRWeb Drug pricing controls imposed by the Inflation Reduction Act of 2022 may appear positive for patients in the short term. However, these controls
Patient recruitment is a major barrier in clinical trials. This involves the identification of patients, screening them for inclusion/exclusion criteria of a given clinical trial,
Information technology, underpinned by advancements in Cloud computing, is no longer the understudy to the scientific, R&D lead. Biotech, pharma, healthcare and medtech organizations need
Even though the COVID-19 pandemic raised global awareness of clinical trials, most adults have never seen an advertisement recruiting volunteers to participate. In the U.S.,
